Novusyn Research is a small editorial desk, and we like it that way. The page lists who writes it, what the editor does and does not do, and how the desk operates. The editor also operates Nexyra Labs, a research-use peptide supplier — a conflict of interest we disclose openly rather than hide, with the full write-up at the ownership disclosure.
How we work: no sponsors in the Brief unless clearly labeled, no paid placement in compound guides, calculators stay free, and AI drafting tools are reviewed by human editors before anything goes live. The full rules are in the Editorial Standards. General questions go to support@novusynresearch.com, corrections to corrections@novusynresearch.com, and supplier applications to suppliers@novusynresearch.com or the application page. The desk publishes research-use-only material and makes no medical claims.